BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Väkevä L, Pukkala E, Ranki A. Increased risk of secondary cancers in patients with primary cutaneous T cell lymphoma. J Invest Dermatol. 2000;115:62-65. [PMID: 10886509 DOI: 10.1046/j.1523-1747.2000.00011.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Trautinger F, Knobler R, Willemze R, Peris K, Stadler R, Laroche L, D’Incan M, Ranki A, Pimpinelli N, Ortiz-Romero P. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome. Eur J Cancer. 2006;42:1014-1030. [PMID: 16574401 DOI: 10.1016/j.ejca.2006.01.025] [Cited by in Crossref: 285] [Cited by in F6Publishing: 192] [Article Influence: 19.0] [Reference Citation Analysis]
2 Pirani M, Marcheselli R, Marcheselli L, Bari A, Federico M, Sacchi S. Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis. Ann Oncol 2011;22:1845-58. [PMID: 21310758 DOI: 10.1093/annonc/mdq697] [Cited by in Crossref: 52] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
3 Jonak C, Alkon N, Rindler K, Rojahn TB, Shaw LE, Porkert S, Weninger W, Trautinger F, Stingl G, Tschandl P, Cerroni L, Farlik M, Brunner PM. Single-cell RNA sequencing profiling in a patient with discordant primary cutaneous B-cell and T-cell lymphoma reveals micromilieu-driven immune skewing. Br J Dermatol 2021. [PMID: 34018188 DOI: 10.1111/bjd.20512] [Reference Citation Analysis]
4 Knobler R, Duvic M, Querfeld C, Straus D, Horwitz S, Zain J, Foss F, Kuzel T, Campbell K, Geskin L. Long-term follow-up and survival of cutaneous T-cell lymphoma patients treated with extracorporeal photopheresis: Long-term treatment of CTCL with ECP. Photodermatol Photoimmunol Photomed 2012;28:250-7. [DOI: 10.1111/j.1600-0781.2012.00689.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
5 Kim YJ, Shin HJ, Won CH, Chang SE, Lee MW, Choi JH, Lee WJ. The Incidence of Other Primary Cancers in Patients with Cutaneous Lymphoma. Ann Dermatol 2018;30:335-41. [PMID: 29853749 DOI: 10.5021/ad.2018.30.3.335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
6 Fung MA, Murphy MJ, Hoss DM, Grant-kels JM. Practical evaluation and management of cutaneous lymphoma. Journal of the American Academy of Dermatology 2002;46:325-60. [DOI: 10.1067/mjd.2002.121355] [Cited by in Crossref: 66] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
7 Hahtola S, Burghart E, Puputti M, Karenko L, Abdel-Rahman WM, Väkevä L, Jeskanen L, Virolainen S, Karvonen J, Salmenkivi K, Kinnula V, Joensuu H, Peltomäki P, Klein CA, Ranki A. Cutaneous T-cell lymphoma-associated lung cancers show chromosomal aberrations differing from primary lung cancer. Genes Chromosomes Cancer 2008;47:107-17. [PMID: 17985357 DOI: 10.1002/gcc.20513] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
8 Marcus Muche J, Karenko L, Gellrich S, Karhu R, Kytölä S, Kähkönen M, Lukowsky A, Sterry W, Ranki A. Cellular coincidence of clonal T cell receptor rearrangements and complex clonal chromosomal aberrations-a hallmark of malignancy in cutaneous T cell lymphoma. J Invest Dermatol 2004;122:574-8. [PMID: 15086537 DOI: 10.1111/j.0022-202X.2004.22303.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
9 Brownell I, Etzel CJ, Yang DJ, Taylor SH, Duvic M. Increased malignancy risk in the cutaneous T-cell lymphoma patient population. Clin Lymphoma Myeloma. 2008;8:100-105. [PMID: 18501103 DOI: 10.3816/clm.2008.n.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, Zackheim H, Duvic M, Estrach T, Lamberg S. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110:1713-1722. [PMID: 17540844 DOI: 10.1182/blood-2007-03-055749] [Cited by in Crossref: 882] [Cited by in F6Publishing: 604] [Article Influence: 63.0] [Reference Citation Analysis]
11 Hallermann C, Kaune Kjell M, Tiemann M, Kunze E, Griesinger F, Mitteldorf C, Bertsch H, Neumann C. High frequency of primary cutaneous lymphomas associated with lymphoproliferative disorders of different lineage. Ann Hematol 2007;86:509-15. [DOI: 10.1007/s00277-007-0276-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
12 Bariani MC, Fleury LF Júnior, Ribeiro AM, Carneiro SS, Pereira TA. Mycosis fungoides and Kaposi's sarcoma association in an HIV-negative patient. An Bras Dermatol 2016;91:108-10. [PMID: 28300912 DOI: 10.1590/abd1806-4841.20164401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Lindahl LM, Fenger-Grøn M, Iversen L. Subsequent cancers, mortality, and causes of death in patients with mycosis fungoides and parapsoriasis: a Danish nationwide, population-based cohort study. J Am Acad Dermatol. 2014;71:529-535. [PMID: 24836079 DOI: 10.1016/j.jaad.2014.03.044] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
14 Goyal A, O'Leary D, Goyal K, Rubin N, Bohjanen K, Hordinsky M, Chen ST, Pongas G, Duncan LM, Lazaryan A. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis. J Am Acad Dermatol 2020;83:404-11. [PMID: 31374302 DOI: 10.1016/j.jaad.2019.07.075] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
15 Saunes M, Lund Nilsen T, Johannesen T. Incidence of primary cutaneous T-cell lymphoma in Norway. British Journal of Dermatology 2009;160:376-9. [DOI: 10.1111/j.1365-2133.2008.08852.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
16 Amber KT, Bloom R, Nouri K. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype. Am J Clin Dermatol. 2016;17:71-77. [PMID: 26386881 DOI: 10.1007/s40257-015-0155-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 4.4] [Reference Citation Analysis]
17 Barzilai A, Trau H, David M, Feinmesser M, Bergman R, Shpiro D, Schiby G, Rosenblatt K, Or R, Hodak E. Mycosis fungoides associated with B-cell malignancies. Br J Dermatol. 2006;155:379-386. [PMID: 16882178 DOI: 10.1111/j.1365-2133.2006.07346.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
18 Wong E, Mahmood MN, Salopek TG. Concomitant B Hairy Cell Leukemia and Mycosis Fungoides in an Elderly Man. Case Rep Dermatol 2017;9:103-7. [PMID: 28512405 DOI: 10.1159/000456650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Karenko L, Hahtola S, Ranki A. Molecular cytogenetics in the study of cutaneous T-cell lymphomas (CTCL). Cytogenet Genome Res 2007;118:353-61. [DOI: 10.1159/000108320] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
20 Gallo E, Pérez-gala S, Navarro R, Fraga J, Adrados M, Arranz R, García-diez A, Aragüés M. Coexistence of marginal zone cutaneous B-cell lymphoma and classic Hodgkin disease: does a biological relationship exist?: Coexistence of MZCBL and cHD. Clin Exp Dermatol 2013;38:383-5. [DOI: 10.1111/j.1365-2230.2012.04478.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
21 . Mycosis fungoides. Skin Lymphoma. Wiley; 2020. pp. 23-112. [DOI: 10.1002/9781119485933.ch3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Cho-vega JH, Tschen JA, Vega F. CD4/CD8 double-negative early-stage mycosis fungoides associated with primary cutaneous follicular center lymphoma. Journal of the American Academy of Dermatology 2011;65:884-6. [DOI: 10.1016/j.jaad.2010.10.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
23 Cather JC, Vance EA, Menter MA. Diverse cutaneous manifestations associated with a single disease. Proc (Bayl Univ Med Cent) 2002;15:433-6. [PMID: 16333475 DOI: 10.1080/08998280.2002.11927876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Wejroch M, Cornillet P, Perceau G, Durlach A, Bernard P. Fréquence des cancers associés dans les lymphomes cutanés. Annales de Dermatologie et de Vénéréologie 2004;131:339-45. [DOI: 10.1016/s0151-9638(04)93612-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Schuler MK, Kroschinsky F, Schaich M, Kalauch A, Stroszczynski C, Kellermann S, Ehninger G, Benter T. Sézary syndrome: infiltration of the gastric wall--does it matter? Ann Hematol. 2012;91:1507-1509. [PMID: 22362119 DOI: 10.1007/s00277-012-1426-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Carbone A, Bernardini L, Valenzano F, Bottillo I, De Simone C, Capizzi R, Capalbo A, Romano F, Novelli A, Dallapiccola B, Amerio P. Array-based comparative genomic hybridization in early-stage mycosis fungoides: recurrent deletion of tumor suppressor genes BCL7A, SMAC/DIABLO, and RHOF. Genes Chromosomes Cancer 2008;47:1067-75. [PMID: 18663754 DOI: 10.1002/gcc.20601] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
27 Ferenczi K, Makkar HS. Cutaneous lymphoma: Kids are not just little people. Clinics in Dermatology 2016;34:749-59. [DOI: 10.1016/j.clindermatol.2016.07.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
28 Hodak E, Amitay I, Feinmesser M, Aviram A, David M. Ichthyosiform mycosis fungoides: An atypical variant of cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology 2004;50:368-74. [DOI: 10.1016/j.jaad.2003.10.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
29 Goyal A, O'Leary D, Goyal K, Patel K, Pearson D, Janakiram M. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer: A systematic review and meta-analysis. J Am Acad Dermatol 2020:S0190-9622(20)32444-0. [PMID: 32822803 DOI: 10.1016/j.jaad.2020.06.1033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
30 Herro E, Dicaudo DJ, Davis MD, Weaver AL, Swanson DL. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic. J Am Acad Dermatol 2009;61:271-5. [PMID: 19481294 DOI: 10.1016/j.jaad.2009.03.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
31 Rausch T, Cairoli A, Benhattar J, Spring P, Hohl D, de Leval L. EBV+ cutaneous B-cell lymphoproliferation of the leg in an elderly patient with mycosis fungoides and methotrexate treatment. APMIS 2013;121:79-84. [DOI: 10.1111/j.1600-0463.2012.02939.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]